Vieser Jaime — SEC insider filings

SEC reporting owner CIK 1846045. 18 insider filings on record with FilingPulse; latest filed 2026-10-08.

Transaction summary — filings shown

Covers all 18 filings on record, filed 2021-05-06 to 2026-10-08. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Alaunos Therapeutics, Inc. (TCRT)Director152 legs · 1,350,000 sh · $1,003,5002 legs · 3,000 sh · $6,02216
Mountain Lake Acquisition Corp. (MLAC)Director31 leg · 25,000 sh—6

Insider filings — Vieser Jaime

FiledFormIssuerReported transactionsSource
2026-10-084Alaunos Therapeutics, Inc. (TCRT)Grant/award (A): 22,669 @ $0.74EDGAR
2026-07-274Alaunos Therapeutics, Inc. (TCRT)Grant/award (A): 8,789 @ $1.92EDGAR
2026-06-154Mountain Lake Acquisition Corp. (MLAC)Disposition to issuer (D): 478,010 · Option exercise (M): 478,010 (derivative)EDGAR
2026-06-044Mountain Lake Acquisition Corp. (MLAC)Other (J): 478,010 (derivative)EDGAR
2026-05-014Alaunos Therapeutics, Inc. (TCRT)Grant/award (A): 6,515 @ $2.59EDGAR
2026-01-154Alaunos Therapeutics, Inc. (TCRT)Grant/award (A): 5,839 @ $2.89EDGAR
2025-11-264Alaunos Therapeutics, Inc. (TCRT)Grant/award (A): 5,340 @ $3.16EDGAR
2025-07-074Alaunos Therapeutics, Inc. (TCRT)Grant/award (A): 3,400 @ $0 · Grant/award (A): 6,400 (derivative) @ $0EDGAR
2025-06-264Alaunos Therapeutics, Inc. (TCRT)Purchase (P): 250 (derivative) @ $4.49EDGAR
2025-04-154Alaunos Therapeutics, Inc. (TCRT)Grant/award (A): 17,465 @ $0EDGAR
2025-01-034Alaunos Therapeutics, Inc. (TCRT)Sale (S): 2,182 @ $2.01 · Sale (S): 818 @ $2EDGAR
2024-12-164Mountain Lake Acquisition Corp. (MLAC)Purchase (P): 25,000 · Grant/award (A): 65,242 (derivative) · Disposition to issuer (D): 65,242 (derivative) · Purchase (P): 25,000 (derivative)EDGAR
2024-06-104Alaunos Therapeutics, Inc. (TCRT)Grant/award (A): 12,800 (derivative) @ $0EDGAR
2023-06-084Alaunos Therapeutics, Inc. (TCRT)Grant/award (A): 100,000 (derivative) @ $0EDGAR
2022-12-014Alaunos Therapeutics, Inc. (TCRT)Purchase (P): 1,250,000 @ $0.65EDGAR
2022-06-244Alaunos Therapeutics, Inc. (TCRT)Grant/award (A): 40,000 @ $0 · Grant/award (A): 100,000 (derivative) @ $0EDGAR
2021-10-044ZIOPHARM ONCOLOGY INC (ZIOP)Purchase (P): 100,000 @ $1.91EDGAR
2021-05-064ZIOPHARM ONCOLOGY INC (ZIOP)Grant/award (A): 4,167 @ $0 · Grant/award (A): 31,250 (derivative) @ $0 · Grant/award (A): 150,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-05-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1846045 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs